18 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
to oversee and direct the Company’s business. To that end, the Committee has identified and evaluated nominees in the broader context of the Board’s overall … , select and oversee management, and establish and oversee processes to maintain our integrity. Our Audit Committee has the responsibility to consider
DEF 14A
9k0sx899lidthv8
27 Apr 22
Definitive proxy
5:03pm
10-K
swj4lmi
28 Mar 22
Annual report
4:51pm
10-Q
3ao66j3 ufli
16 Aug 21
Quarterly report
4:51pm
424B4
hm84l vcxoz80phvhug
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.1
i7zp1xjadgq21142cav
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
271yv8n1z5 2nx23uans
24 Jun 21
IPO registration (amended)
8:17am
S-1
EX-10.1
x62vydeis3zfs
9 Jun 21
IPO registration
5:02pm
S-1
5g0f2wnjf4kzdwc2em2
9 Jun 21
IPO registration
5:02pm
DRS/A
EX-10.1
rfwy7
3 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
ig3h74gwu42cn7
14 May 21
Draft registration statement (amended)
12:00am
DRS
ij41duhzg yaczr4a7
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next